Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vaishali Pharma Ltd. ( (IN:VAISHALI) ) has shared an update.
Vaishali Pharma Limited has announced that it has received approval from the National Stock Exchange of India Limited for the trading of 23,270,000 equity shares, each valued at ₹2. These shares were issued to both promoters and non-promoters on a preferential basis following the conversion of warrants. The shares have been listed and are available for trading on the exchange as of December 9, 2025. This development signifies a strategic move by Vaishali Pharma to enhance its capital structure and potentially improve its market positioning, offering new opportunities for stakeholders and investors.
More about Vaishali Pharma Ltd.
Average Trading Volume: 380,375
Technical Sentiment Signal: Sell
Current Market Cap: 902.6M INR
For detailed information about VAISHALI stock, go to TipRanks’ Stock Analysis page.